Latest Issue of The Motivator Now Available for the MS Community

savas2The Motivator is MSAA’s award-winning magazine provided to the MS community and to our generous supporters. Distributed twice per year, this publication addresses the physical, emotional, and social issues that arise with MS, and provides information and support to many individuals affected by this disorder.

We’re pleased to announce that the Winter/Spring 2014 issue of The Motivator is now available to read!

savas

Cover Story:
The Emotional and Psychological Symptoms of MS
… The symptoms of depression, anxiety, and pseudobulbar affect (PBA) are described, along with effective treatment strategies. Important information is also given on how these symptoms affect roles and relationships, sexual function, and self-image.
Read the full story

Feature Story:
…Competitive “biosimilar” drugs may soon be considered for approval. Read about how these “highly similar” drugs may affect procedure, treatment, and cost.
Read the full story

AquaticCenter-Screen

Program Notes:
…Details on MSAA’s new Swim for MS online Aquatic Center are highlighted. This national program initiative supports the awareness, understanding, and availability of swimming and aquatic exercise as a positive wellness opportunity for the MS community.
Read the full story

Read the latest issue of The Motivator

 

Share

Read MSAA’s latest issue of The Motivator

Cover for Summer-Fall 2012 issue of The MotivatorThe latest issue of MSAA’s magazine, The Motivator, is out now – read it online, download a version to your computer, or order a copy today.

Included in the online issue:

* Cover Story – The Evolution of MS Diagnosis, Treatment, and Care

* Research News – Aubagio® approval and other research updates

* Health and Wellness – The benefits of aquatic therapy and exercise

…Plus, extra “Ask the Doctor” answers, not included in the printed magazine!

*********************

The Evolution of MS Diagnosis, Treatment, and Care:

From the mid-1800s to the late 1900s, diagnostic criteria and therapies were fraught with uncertainty – and required more than a century of trial and error to reach today’s high level of success. Seventeen MS specialists are quoted, giving details about the most important contributions in MS history.

Read the full story

Research News:

Read about the recent FDA-approval of Aubagio® (teriflunomide), as well as updates on DMF (dimethyl fumarate) and Lemtrada™ (alemtuzumab), both submitted for FDA approval.

Read the full story

Health and Wellness:

Aquatic therapy and aquatic exercise are described, along with the benefits that they offer to individuals with MS.

Read the full story

The Motivator is MSAA’s award-winning magazine provided to the MS community and to our generous supporters.

Read the latest issue of The Motivator

Share